Executive Vice President, Strategy & Commercial Op
She is Executive Vice President of Strategy & Commercial Operations at Pfizer. She is responsible for overseeing the shaping of Pfizer’s longer-term strategy, supporting the execution for Pfizer’s commercial objectives, and providing portfolio advisory functions to guide R&D investment decisions. Laurie is a member of Pfizer’s Executive Leadership Team and also a member of the Portfolio Strategy Investment Committee, which oversees decisions regarding enterprise portfolio investment and advancement. She joined Pfizer in 1987 as an analyst in the company’s Marketing Research organization. She has since held both U.S. and global leadership roles in marketing, commercial development, strategy, analytics and operations. In her most recent role as Senior Vice President, Portfolio Management and Analytics, she served on an executive task force that successfully redesigned Pfizer’s R&D organization to strengthen its pipeline and improve efficiency. In 2011, Corporate Strategy was added to her responsibilities. In addition to her daily responsibilities, she is the executive sponsor of Pfizer’s global Lesbian, Gay, Bisexual, and Transgender Colleague Council and serves on the company’s worldwide Diversity Leadership Council. Laurie earned a Bachelor of Science degree in Economics from the State University of New York at Stony Brook and an M.B.A. in Marketing from Hofstra University.